Front Row Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-97
| Closed | -$6.64K | – | 863 |
|
|
2024
Q2 | $6.64K | Sell |
97
-36
| -27% | -$2.47K | ﹤0.01% | 677 |
|
|
2024
Q1 | $9.2K | Buy |
+133
| New | +$9.2K | ﹤0.01% | 611 |
|
|
2023
Q4 | – | Sell |
-117
| Closed | -$6.1K | – | 830 |
|
|
2023
Q3 | $6.1K | Buy |
117
+9
| +8% | +$469 | ﹤0.01% | 626 |
|
|
2023
Q2 | $7K | Hold |
108
| – | – | ﹤0.01% | 612 |
|
|
2023
Q1 | $6K | Buy |
108
+23
| +27% | +$1.28K | ﹤0.01% | 647 |
|
|
2022
Q4 | $4K | Hold |
85
| – | – | ﹤0.01% | 709 |
|
|
2022
Q3 | $4K | Buy |
+85
| New | +$4K | ﹤0.01% | 726 |
|